SEC Form 4 · accession 0001171843-16-010872
Xenon Pharmaceuticals Inc. · XENE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ian Mortimer
Officer — CFO & COO
Period of report
Jun 24, 2016
Accepted (ET)
Jun 28, 2016 · 4:41 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001582313
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 24, 2016 | P | 1,000 | $6.15 | A | 1,000 | D | |
| Common Stock | Jun 24, 2016 | P | 1,000 | $6.10 | A | 1,000 | I | By spouse |
| Common Stock | Jun 24, 2016 | P | 2,000 | $6.25 | A | 3,000 | I | By spouse |
| Common Stock | Jun 24, 2016 | P | 1,300 | $6.30 | A | 4,300 | I | By spouse |
Table II — derivative securities
No Table II lines on this filing.